Nykredit A/S’s Cogent Biosciences COGT Stock Holding History

Nykredit A/S’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$159K	Buy	+4,114	New	+$144K	﹤0.01%	1131

Other funds holding COGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nykredit A/S's COGT Position: Q2 2026 in Review

Nykredit A/S opened a new position in Cogent Biosciences (COGT) in Q2 2026: 4,114 shares worth $159K. The stake represents ﹤0.01% of the portfolio and ranks #1131 among its holdings.

190 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Nykredit A/S held 4,114 shares of Cogent Biosciences worth $159K as of Q2 2026.
Cogent Biosciences was a new Nykredit A/S position in Q2 2026.
Cogent Biosciences made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1131 holding.
190 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.